Nasdaq · CIK 0001410098
CRMD CorMedix Inc.
Insider trading from SEC Form 4. Last filing 24 d ago. Close $7.38 on Oct 9, 2026, +18% from the 52-week low and -42% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
CRMDOct 9, 2026 · close 7.38
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CorMedix Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Joseph Todisco Chief Executive Officer sell | $360k 30,000 shares | -6% | +103% from low-28% from high | |
| 21Weak | Janet Dillione director sell | $408k 34,000 shares | -41% | +98% from low-30% from high | |
| 58Moderate | Steven W Lefkowitz director sell | $475k 40,000 shares | -33% | +98% from low-30% from high | |
| 15Weak | Janet Dillione director sell | $467k 46,657 shares | -49% | +67% from low-41% from high | |
| 23Weak | Janet Dillione director sell | $262k 26,343 shares | -35% | +68% from low-41% from high | |
| 40Moderate | Janet Dillione director sell | $343k 30,000 shares | -38% | +92% from low-32% from high | |
| 40Moderate | Myron Kaplan director buy | $276k 25,000 shares | +14% | +93% from low-32% from high | |
| 31Weak | Alan W Dunton director sell | $131k 10,000 shares | -20% | +121% from low-22% from high | |
| 45Moderate | Joseph Todisco Chief Executive Officer sell | $650k 50,000 shares | -9% | +121% from low-22% from high | |
| 51Moderate | Elizabeth Hurlburt Chief Operating Officer sell | $712k 53,997 shares | -28% | +122% from low-21% from high | |
| 40Moderate | Kaufman Beth Zelnick Chief Legal Officer sell | $670k 50,000 shares | -22% | +122% from low-21% from high | |
| 15Weak | Erin Mistry EVP, Chief Commercial Officer buy | $15k 1,500 shares | +3% | - | |
| 45Moderate | Elizabeth Hurlburt EVP sell | $1.6M 140,027 shares | -76% | - |
Transactions
The last 98 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Janet Dillione director | MOption exercise Common Stock | +48,909 | - | - | 117,835 | 24 d ago |
| Sep 18, 2026 | Janet Dillione director | MOption exercise Phantom Stockderivative | -48,909 | - | - | 0 | 24 d ago |
| Aug 29, 2026 | Kaufman Beth Zelnick Chief Legal Officer | FTax withholding Common Stock | -8,424 | $8.30 | $70k | 260,684 | 41 d ago |
| Aug 29, 2026 | Elizabeth Hurlburt Chief Operating Officer | FTax withholding Common Stock | -8,076 | $8.30 | $67k | 270,463 | 41 d ago |
| Aug 29, 2026 | Susan Blum Chief Financial Officer | FTax withholding Common Stock | -8,424 | $8.30 | $70k | 124,315 | 41 d ago |
| Dec 18, 2025 | Joseph Todisco Chief Executive Officer | MOption exercise Common Stock10b5-1 | +30,000 | $4.43 | $133k | 539,496 | Dec 19, 2025 |
| Dec 18, 2025 | Joseph Todisco Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -30,000 | $12.00 | $360k | 509,496 | Dec 19, 2025 |
| Dec 18, 2025 | Joseph Todisco Chief Executive Officer | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -30,000 | $0.00 | $0 | 370,000 | Dec 19, 2025 |
| Dec 9, 2025 | Janet Dillione director | MOption exercise Common Stock10b5-1 | +19,000 | $9.55 | $181k | 67,473 | Dec 11, 2025 |
| Dec 9, 2025 | Janet Dillione director | MOption exercise Common Stock10b5-1 | +15,000 | $5.63 | $84k | 82,473 | Dec 11, 2025 |
| Dec 9, 2025 | Janet Dillione director | SOpen-market sale Common Stock10b5-1 | -34,000 | $12.00 | $408k | 48,473 | Dec 11, 2025 |
| Dec 9, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -19,000 | $0.00 | $0 | 0 | Dec 11, 2025 |
| Dec 9, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -15,000 | $0.00 | $0 | 0 | Dec 11, 2025 |
| Dec 9, 2025 | Steven W Lefkowitz director | SOpen-market sale Common Stock | -40,000 | $11.88 | $475k | 80,498 | Dec 10, 2025 |
| Dec 2, 2025 | Janet Dillione director | MOption exercise Common Stock10b5-1 | +12,210 | $4.03 | $49k | 60,683 | Dec 4, 2025 |
| Dec 2, 2025 | Janet Dillione director | MOption exercise Common Stock10b5-1 | +15,124 | $4.43 | $67k | 75,807 | Dec 4, 2025 |
| Dec 2, 2025 | Janet Dillione director | MOption exercise Common Stock10b5-1 | +19,323 | $3.55 | $69k | 95,130 | Dec 4, 2025 |
| Dec 2, 2025 | Janet Dillione director | SOpen-market sale Common Stock10b5-1 | -46,657 | $10.00 | $467k | 48,473 | Dec 4, 2025 |
| Dec 2, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -12,210 | $0.00 | $0 | 0 | Dec 4, 2025 |
| Dec 2, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -15,124 | $0.00 | $0 | 0 | Dec 4, 2025 |
| Dec 2, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative10b5-1 | -19,323 | $0.00 | $0 | 5,000 | Dec 4, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Common Stock | +8,000 | $2.85 | $23k | 56,473 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Common Stock | +7,790 | $4.03 | $31k | 64,263 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Common Stock | +4,876 | $4.43 | $22k | 69,139 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Common Stock | +5,677 | $3.55 | $20k | 74,816 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | SOpen-market sale Common Stock | -26,343 | $9.93 | $262k | 48,473 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -8,000 | $0.00 | $0 | 0 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -7,790 | $0.00 | $0 | 12,210 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -4,876 | $0.00 | $0 | 15,124 | Nov 26, 2025 |
| Nov 24, 2025 | Janet Dillione director | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -5,677 | $0.00 | $0 | 24,323 | Nov 26, 2025 |
| Nov 14, 2025 | Janet Dillione director | SOpen-market sale Common Stock | -30,000 | $11.42 | $343k | 48,473 | Nov 18, 2025 |
| Oct 23, 2025 | Myron Kaplan director | POpen-market purchase Common Stock | +25,000 | $11.02 | $276k | 201,034 | Oct 27, 2025 |
| Sep 16, 2025 | Gregory Scott Duncan director | MOption exercise Common Stock | +13,333 | $8.32 | $111k | 38,333 | Sep 18, 2025 |
| Sep 16, 2025 | Gregory Scott Duncan director | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -13,333 | $0.00 | $0 | 6,667 | Sep 18, 2025 |
| Sep 12, 2025 | Alan W Dunton director | MOption exercise Common Stock | +10,000 | $3.55 | $36k | 50,250 | Sep 16, 2025 |
| Sep 12, 2025 | Alan W Dunton director | SOpen-market sale Common Stock | -10,000 | $13.13 | $131k | 40,250 | Sep 16, 2025 |
| Sep 12, 2025 | Alan W Dunton director | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -10,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
| Sep 12, 2025 | Joseph Todisco Chief Executive Officer | MOption exercise Common Stock | +50,000 | $3.47 | $174k | 559,496 | Sep 12, 2025 |
| May 10, 2025 | Joseph Todisco Chief Executive Officer | FTax withholding Common Stock | -21,225 | $11.66 | $247k | 509,496 | Sep 12, 2025 |
| Sep 12, 2025 | Joseph Todisco Chief Executive Officer | SOpen-market sale Common Stock | -50,000 | $13.00 | $650k | 509,496 | Sep 12, 2025 |
| Sep 12, 2025 | Joseph Todisco Chief Executive Officer | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -50,000 | $0.00 | $0 | 216,667 | Sep 12, 2025 |
| Sep 9, 2025 | Elizabeth Hurlburt Chief Operating Officer | MOption exercise Common Stock | +12,876 | $1.45 | $19k | 189,866 | Sep 11, 2025 |
| Sep 9, 2025 | Kaufman Beth Zelnick Chief Legal Officer | MOption exercise Common Stock | +50,000 | $3.30 | $165k | 230,418 | Sep 11, 2025 |
| Sep 9, 2025 | Elizabeth Hurlburt Chief Operating Officer | SOpen-market sale Common Stock | -12,876 | $13.51 | $174k | 176,990 | Sep 11, 2025 |
| Sep 9, 2025 | Kaufman Beth Zelnick Chief Legal Officer | SOpen-market sale Common Stock | -49,600 | $13.41 | $665k | 180,818 | Sep 11, 2025 |
| Sep 11, 2025 | Elizabeth Hurlburt Chief Operating Officer | MOption exercise Common Stock | +41,121 | $1.45 | $60k | 218,111 | Sep 11, 2025 |
| Sep 9, 2025 | Kaufman Beth Zelnick Chief Legal Officer | SOpen-market sale Common Stock | -400 | $12.82 | $5,128 | 180,418 | Sep 11, 2025 |
| Sep 9, 2025 | Kaufman Beth Zelnick Chief Legal Officer | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -50,000 | $0.00 | $0 | 150,000 | Sep 11, 2025 |
| Sep 11, 2025 | Elizabeth Hurlburt Chief Operating Officer | SOpen-market sale Common Stock | -41,121 | $13.08 | $538k | 176,990 | Sep 11, 2025 |
| Sep 9, 2025 | Elizabeth Hurlburt Chief Operating Officer | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -12,876 | $0.00 | $0 | 41,121 | Sep 11, 2025 |
| Sep 11, 2025 | Elizabeth Hurlburt Chief Operating Officer | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -41,121 | $0.00 | $0 | 0 | Sep 11, 2025 |
| Aug 29, 2025 | Kaufman Beth Zelnick Chief Legal Officer | FTax withholding Common Stock | -8,880 | $14.83 | $132k | 180,418 | Sep 8, 2025 |
| Aug 29, 2025 | Elizabeth Hurlburt Chief Operating Officer | FTax withholding Common Stock | -8,424 | $14.83 | $125k | 176,990 | Sep 8, 2025 |
| Aug 29, 2025 | Susan Blum Chief Financial Officer | AGrant or award Common Stock | +69,686 | $0.00 | $0 | 69,686 | Sep 3, 2025 |
| Aug 29, 2025 | Kaufman Beth Zelnick Chief Legal Officer | AGrant or award Common Stock | +69,686 | $0.00 | $0 | 189,298 | Sep 3, 2025 |
| Aug 29, 2025 | Elizabeth Hurlburt Chief Operating Officer | AGrant or award Common Stock | +69,686 | $0.00 | $0 | 185,414 | Sep 3, 2025 |
| Apr 2, 2025 | Steven W Lefkowitz director | MOption exercise Common Stock | +20,000 | $4.03 | $81k | 120,498 | Apr 3, 2025 |
| Apr 2, 2025 | Steven W Lefkowitz director | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -20,000 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | Joseph Todisco Chief Executive Officer | MOption exercise Common Stock | +59,170 | $3.38 | $200k | 530,721 | Apr 2, 2025 |
| Apr 1, 2025 | Joseph Todisco Chief Executive Officer | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -59,170 | $0.00 | $0 | 440,830 | Apr 2, 2025 |
| Jan 17, 2025 | Janet Dillione director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 78,473 | Jan 22, 2025 |
| Jan 17, 2025 | Joseph Todisco Chief Executive Officer | AGrant or award Common Stock | +187,500 | $0.00 | $0 | 495,528 | Jan 22, 2025 |
| Jan 17, 2025 | Alan W Dunton director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 40,250 | Jan 22, 2025 |
| Jan 17, 2025 | Robert A Stewart director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 36,000 | Jan 22, 2025 |
| Jan 17, 2025 | Myron Kaplan director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 176,034 | Jan 22, 2025 |
| Jan 17, 2025 | Steven W Lefkowitz director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 100,498 | Jan 22, 2025 |
| Jan 17, 2025 | Gregory Scott Duncan director | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 25,000 | Jan 22, 2025 |
| Jan 17, 2025 | Joseph Todisco Chief Executive Officer | FTax withholding Common Stock | -23,977 | $12.17 | $292k | 471,551 | Jan 22, 2025 |
| Jan 10, 2025 | Elizabeth Hurlburt EVP | FTax withholding Common Stock | -5,790 | $11.19 | $65k | 115,728 | Jan 14, 2025 |
| Jan 10, 2025 | Erin Mistry EVP, Chief Commercial Officer | FTax withholding Common Stock | -5,689 | $11.19 | $64k | 100,992 | Jan 14, 2025 |
| Jan 10, 2025 | Joseph Todisco Chief Executive Officer | FTax withholding Common Stock | -17,829 | $11.19 | $200k | 308,028 | Jan 14, 2025 |
| Jan 10, 2025 | Matthew T David Chief Financial Officer | FTax withholding Common Stock | -6,515 | $11.19 | $73k | 95,270 | Jan 14, 2025 |
| Jan 2, 2025 | Kaufman Beth Zelnick Chief Legal Officer | AGrant or award Common Stock | +87,500 | $0.00 | $0 | 131,456 | Jan 6, 2025 |
| Jan 2, 2025 | Matthew T David Chief Financial Officer | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 110,434 | Jan 6, 2025 |
| Jan 2, 2025 | Elizabeth Hurlburt EVP | AGrant or award Common Stock | +87,500 | $0.00 | $0 | 132,897 | Jan 6, 2025 |
| Jan 2, 2025 | Erin Mistry EVP, Chief Commercial Officer | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 114,511 | Jan 6, 2025 |
| Jan 2, 2025 | Kaufman Beth Zelnick Chief Legal Officer | FTax withholding Common Stock | -11,844 | $8.22 | $97k | 119,612 | Jan 6, 2025 |
| Jan 2, 2025 | Erin Mistry EVP, Chief Commercial Officer | FTax withholding Common Stock | -7,830 | $8.22 | $64k | 106,681 | Jan 6, 2025 |
| Jan 2, 2025 | Matthew T David Chief Financial Officer | FTax withholding Common Stock | -8,648 | $8.22 | $71k | 101,786 | Jan 6, 2025 |
| Jan 2, 2025 | Elizabeth Hurlburt EVP | FTax withholding Common Stock | -11,378 | $8.22 | $94k | 121,519 | Jan 6, 2025 |
| Dec 12, 2024 | Kaufman Beth Zelnick Chief Legal Officer | FTax withholding Common Stock | -6,044 | $8.77 | $53k | 43,956 | Dec 18, 2024 |
| Dec 12, 2024 | Kaufman Beth Zelnick Chief Legal Officer | MOption exercise Common Stock | +12,500 | - | - | 62,500 | Dec 16, 2024 |
| Dec 12, 2024 | Kaufman Beth Zelnick Chief Legal Officer | FTax withholding Common Stock | -6,044 | $8.77 | $53k | 56,456 | Dec 16, 2024 |
| Dec 12, 2024 | Kaufman Beth Zelnick Chief Legal Officer | MOption exercise Restricted Stock Unitsderivative | -12,500 | $0.00 | $0 | 37,500 | Dec 16, 2024 |
| Oct 31, 2024 | Erin Mistry EVP, Chief Commercial Officer | POpen-market purchase Common Stock | +1,500 | $9.99 | $15k | 52,011 | Dec 13, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Common Stock | +3 | $1.45 | $4 | 45,400 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Common Stock | +8,169 | $8.30 | $68k | 53,569 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Common Stock | +9,888 | $5.63 | $56k | 63,457 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Common Stock | +34,467 | $4.08 | $141k | 97,924 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Common Stock | +62,500 | $4.43 | $277k | 160,424 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Common Stock | +25,000 | $3.47 | $87k | 185,424 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | SOpen-market sale Common Stock | -140,027 | $11.18 | $1.6M | 45,397 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -3 | $0.00 | $0 | 53,997 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -8,169 | $0.00 | $0 | 12,711 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -9,888 | $0.00 | $0 | 27,612 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -34,467 | $0.00 | $0 | 3,033 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -62,500 | $0.00 | $0 | 62,500 | Nov 18, 2024 |
| Nov 14, 2024 | Elizabeth Hurlburt EVP | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -25,000 | $0.00 | $0 | 75,000 | Nov 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Susan BlumChief Financial Officer
- Alan W Duntondirector
- Matthew T DavidChief Financial Officer
- Janet Dillionedirector
- Gregory Scott Duncandirector, ceo, officer
- Elizabeth HurlburtChief Operating Officer
- Myron Kaplandirector
- Steven W Lefkowitzdirector
- Erin MistryEVP, Chief Commercial Officer
- Robert A Stewartdirector
- Joseph TodiscoChief Executive Officer
- Kaufman Beth ZelnickChief Legal Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.